Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival.

Korean J Clin Oncol · 2021 · PMC9942742 · PMID 36945205

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Also, postoperative complications requiring intervention or additional operation showed a trend to interfere with adherence to adjuvant therapy.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.